The BTLA (ICAToli Biosimilar) Antibody (HDBS0053) is a high-quality research tool designed for studying BTLA, a co-inhibitory immune checkpoint receptor involved in the regulation of immune responses. This antibody, produced through a biosimilar process, exhibits high reactivity with human samples and is validated for use in various immunological assays, including Western blotting.BTLA, or B and T lymphocyte attenuator, plays a pivotal role in modulating immune responses by suppressing T cell activation and cytokine production. Dysregulation of BTLA signaling has been implicated in various diseases, including cancer and autoimmune disorders, making it a promising target for therapeutic intervention.
Research on BTLA function and signaling pathways is crucial for developing novel immunotherapies and understanding immune system dysregulation in disease settings.Overall, the Anti-BTLA (ICAToli Biosimilar) Antibody (HDBS0053) serves as a valuable tool for investigating the role of BTLA in immune regulation and disease pathogenesis, providing new insights into potential therapeutic strategies for immune-related disorders.
Product Name:
Icatolimab Biosimilar (BTLA) Antibody (HDBS0053)
Size:
100 ug
Product SKU:
HDBS0053
Target:
BTLA
Host Species:
Chimeric
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
JS004
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
